FII Holdings

JUBILANT PHARMOVA LTD.

NSE : JUBLPHARMABSE : 530019ISIN CODE : INE700A01033Industry : Pharmaceuticals & DrugsHouse : Jubilant Bhartia
BSE830.5521.65 (+2.68 %)
PREV CLOSE ( ) 808.90
OPEN PRICE ( ) 809.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11493
TODAY'S LOW / HIGH ( )788.55 834.85
52 WK LOW / HIGH ( )783.75 1250
NSE827.6520 (+2.48 %)
PREV CLOSE( ) 807.65
OPEN PRICE ( ) 804.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 827.65 (5)
VOLUME 247175
TODAY'S LOW / HIGH( ) 789.70 834.00
52 WK LOW / HIGH ( )786.05 1248
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202603 % of Share Quarter Ended 202512 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.